Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction
Megaly M, Buda KG, Xenogiannis I, Vemmou E, Nikolakopoulos I, Saad M, Rinfret S, Abbott JD, Aronow HD, Garcia S, Pershad A, Burke MN, Brilakis ES. Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction. Cardiovascular Intervention And Therapeutics 2020, 36: 481-489. PMID: 33037991, DOI: 10.1007/s12928-020-00713-y.Peer-Reviewed Original ResearchConceptsDrug-coated balloonsAcute myocardial infarctionMyocardial infarctionAMI patientsOutcomes of DCBMajor adverse cardiovascular eventsAdverse cardiovascular eventsLate lumen lossShort-term outcomesLesion revascularizationCardiovascular eventsCause mortalityAngiographic outcomesCardiac deathLumen lossSimilar riskClinical utilityPatientsSystematic reviewLarger studyInfarctionStatistical differenceOutcomesMonthsBalloonOutcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Omer M, Willson L, Monyak DJ, Sullivan P, Stanberry L, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES. Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis. Cardiovascular Revascularization Medicine 2020, 22: 29-33. PMID: 32571761, DOI: 10.1016/j.carrev.2020.06.019.Peer-Reviewed Original ResearchConceptsTarget lesion failureTarget lesion revascularizationLong-term outcomesVascular brachytherapyDrug-eluting stentsMyocardial infarctionLaser atherectomyDES-ISRCardiac deathStent restenosisIncidence of TLFComparable long-term outcomesRecurrent DES-ISRExcimer laser atherectomyLesion myocardial infarctionTarget-lesion myocardial infarctionRecurrent drugsLesion failureLesion revascularizationISR lesionsStent underexpansionSingle institutionTarget lesionsAtherectomyStudy periodOutcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Willson L, Monyak DJ, Sullivan P, Stanberry L, Sorajja P, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES. Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis. Catheterization And Cardiovascular Interventions 2020, 97: 32-38. PMID: 31943747, DOI: 10.1002/ccd.28716.Peer-Reviewed Original ResearchConceptsTarget lesion failureTarget lesion revascularizationRecurrent DES-ISRAcute coronary syndromeVascular brachytherapyDrug-eluting stentsDES-ISRMyocardial infarctionLower incidenceInitial presentationStent restenosisIncidence of TLRHigher TLFUse of IVUSProportional hazards analysisTertiary care institutionIntravascular ultrasound guidanceLong-term outcomesLesion myocardial infarctionTarget-lesion myocardial infarctionLesion revascularizationCoronary syndromeLesion failureCardiac deathUltrasound guidance